Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jukka Westerbacka

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Diabetes, Obesity & Metabolism|November 25, 2020
How many people with type 2 diabetes fulfil the eligibility criteria for randomized, controlled trials of insulin glargine 300 U/mL in a real-world setting?Dídac Mauricio, Jukka Westerbacka, Charlie Nicholls, et al.
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine|June 3, 2014
Ultra-acute increase in blood glucose during prehospital phase is associated with worse short-term and long-term survival in ST-elevation myocardial infarctionHanna Vihonen, Ilkka Tierala, Markku Kuisma, et al.
The Journal of Clinical Endocrinology and Metabolism|June 28, 2007
Liver fat in the metabolic syndromeAnna Kotronen, Jukka Westerbacka, Robert Bergholm, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|April 19, 2011
Strict glucose control after acute stroke can be provided in the prehospital settingJouni Nurmi, Perttu J Lindsberg, Olli Häppölä, et al.
NMR in Biomedicine|September 8, 2010
Long-TE 1H MRS suggests that liver fat is more saturated than subcutaneous and visceral fatJesper Lundbom, Antti Hakkarainen, Sanni Söderlund, et al.
Diabetes, Obesity & Metabolism|May 2, 2022
Real-world outcomes of addition of insulin glargine 300 U/mL (Gla-300) to glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy in people with type 2 diabetes: The DELIVER-G studyTimothy S Bailey, Jasvinder Gill, Merwyn Jones S, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 15, 2002
Inhibition of platelet-collagen interaction: an in vivo action of insulin abolished by insulin resistance in obesityJukka Westerbacka, Hannele Yki-Järvinen, Anu Turpeinen, et al.
NMR in Biomedicine|January 26, 2010
Characterizing human adipose tissue lipids by long echo time 1H-MRS in vivo at 1.5 Tesla: validation by gas chromatographyJesper Lundbom, Antti Hakkarainen, Barbara Fielding, et al.
Diabetes Care|October 16, 2007
Liver fat is increased in type 2 diabetic patients and underestimated by serum alanine aminotransferase compared with equally obese nondiabetic subjectsAnna Kotronen, Leena Juurinen, Antti Hakkarainen, et al.
The Journal of Clinical Endocrinology and Metabolism|May 10, 2007
Postprandial lipemia associates with liver fat contentNiina Matikainen, Sakari Mänttäri, Jukka Westerbacka, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Diabetes, Obesity & Metabolism|November 25, 2020
How many people with type 2 diabetes fulfil the eligibility criteria for randomized, controlled trials of insulin glargine 300 U/mL in a real-world setting?Dídac Mauricio, Jukka Westerbacka, Charlie Nicholls, et al.
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine|June 3, 2014
Ultra-acute increase in blood glucose during prehospital phase is associated with worse short-term and long-term survival in ST-elevation myocardial infarctionHanna Vihonen, Ilkka Tierala, Markku Kuisma, et al.
The Journal of Clinical Endocrinology and Metabolism|June 28, 2007
Liver fat in the metabolic syndromeAnna Kotronen, Jukka Westerbacka, Robert Bergholm, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|April 19, 2011
Strict glucose control after acute stroke can be provided in the prehospital settingJouni Nurmi, Perttu J Lindsberg, Olli Häppölä, et al.
NMR in Biomedicine|September 8, 2010
Long-TE 1H MRS suggests that liver fat is more saturated than subcutaneous and visceral fatJesper Lundbom, Antti Hakkarainen, Sanni Söderlund, et al.
Diabetes, Obesity & Metabolism|May 2, 2022
Real-world outcomes of addition of insulin glargine 300 U/mL (Gla-300) to glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy in people with type 2 diabetes: The DELIVER-G studyTimothy S Bailey, Jasvinder Gill, Merwyn Jones S, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 15, 2002
Inhibition of platelet-collagen interaction: an in vivo action of insulin abolished by insulin resistance in obesityJukka Westerbacka, Hannele Yki-Järvinen, Anu Turpeinen, et al.
NMR in Biomedicine|January 26, 2010
Characterizing human adipose tissue lipids by long echo time 1H-MRS in vivo at 1.5 Tesla: validation by gas chromatographyJesper Lundbom, Antti Hakkarainen, Barbara Fielding, et al.
Diabetes Care|October 16, 2007
Liver fat is increased in type 2 diabetic patients and underestimated by serum alanine aminotransferase compared with equally obese nondiabetic subjectsAnna Kotronen, Leena Juurinen, Antti Hakkarainen, et al.
The Journal of Clinical Endocrinology and Metabolism|May 10, 2007
Postprandial lipemia associates with liver fat contentNiina Matikainen, Sakari Mänttäri, Jukka Westerbacka, et al.
Pageof 6